ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is China Pharma Holdings, Inc. ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-18.08%
EBIT Growth (5y)
-0.58%
EBIT to Interest (avg)
-3.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.51
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.37%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.38
EV to EBIT
-1.97
EV to EBITDA
-3.57
EV to Capital Employed
0.55
EV to Sales
1.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.79%
ROE (Latest)
-37.55%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at USD -2.37 MM
ROCE(HY)
Highest at -15.99%
DEBT-EQUITY RATIO
(HY)
Lowest at 9.11 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.99 times
OPERATING PROFIT(Q)
Highest at USD -0.14 MM
EPS(Q)
Highest at USD -0.04
-5What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -1.14 MM has Fallen at -45.52%
NET PROFIT(Q)
At USD -1.14 MM has Fallen at -45.52%
RAW MATERIAL COST(Y)
Grown by 108.12% (YoY
Here's what is working for China Pharma Holdings, Inc.
Operating Profit
Highest at USD -0.14 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
EPS
Highest at USD -0.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at 9.11 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.99 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for China Pharma Holdings, Inc.
Pre-Tax Profit
At USD -1.14 MM has Fallen at -45.52%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -1.14 MM has Fallen at -45.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Raw Material Cost
Grown by 108.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
